plenary sessions
Plenary I: Presidential Symposium
This Presidential Symposium spans molecular, developmental, and translational research, bringing together internationally recognized pioneers who are transforming our understanding of human biology and enabling new approaches to disease and therapy.
Carolyn Bertozzi, PhD
Stanford University, USA
Douglas Melton, PhD
Vertex Pharmaceuticals, USA
Plenary II: The Bioengineering Bridge
This session highlights advances in synthetic biology, biomaterials, organoid engineering, and organ-on-chip technologies, illuminating how bioengineering bridges fundamental stem cell biology insights with therapeutic applications.
Michael B. Elowitz, PhD
California Institute of Technology, USA
Seung-Woo Cho, PhD
Yonsei University, Korea
Plenary III: Clinical Translation and Patient Impact
This session showcases clinical advances in stem cell and regenerative medicine, including disease modeling for drug discovery, gene therapy, and cell therapy, with attention to the challenges of achieving widely accessible treatments and their impact on patients.
Frederic J. de Sauvage, PhD
Genentech, USA
Plenary IV: The Artificial Intelligence Evolution
This session explores how artificial intelligence is transforming stem cell research through predictive modeling of cell fate, high-throughput screening, and laboratory automation, as well as emerging clinical applications such as digital twins and ethical considerations for these approaches.
Allon M. Klein, PhD
Harvard Medical School, USA
Prisca Liberali, PhD
Friedrich Miescher Institute for Biomedical Research (FMI) and DBSSE - ETH Zürich, Switzerland
Plenary V: Awards
This capstone session features award presentations and lectures by the ISSCR Early Career Impact, Momentum, Lifetime Achievement, and Public Service Award winners.